Genetic - Medika Life

This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Whatever Happened to Isometrics as a Promising Muscle-Management Method?

Pat Farrell PhD - June 23, 2024

Exercise can be simple and a snap to incorporate into your life without equipment, and you can do it wherever you are, whenever you can.

Are Your Patients Asking about Wegovy?

Katherine Saunders, MD - September 20, 2023

Ten common questions about popular anti-obesity medications

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

The Best Dating Game in Health Innovation Happens Just Off the Main Stage

Treating Rare Diseases: The Challenge of Access

The Strange Link Between Light Exposure and Weight Gain

The Body’s Amazing Repair Crew: Stem Cells

LATEST

TRENDING

Alagille syndrome

Health Possibilities We Can’t Afford to Block

Lupus and its effects on women

The SERPINA1 Gene, serpin family A member 1

BRCA1 and 2: The Breast Cancer Genes

FBN1 gene, fibrillin 1

Marfan Syndrome (MFS)

Loeys-Dietz syndrome (LDS)

Looking for Zebras: Medical Mysteries and Transformational Patient Moments

When It Comes to the Future of HLTH – Life Is Not a Las Vegas Roulette Wheel

EDITORS CHOICE

The Tricky Politics of Healthy Ageing

Researchers Control Cancer Treatment With New Innovation: CAR T Switch(Blade)

Whatever Happened to Isometrics as a Promising Muscle-Management Method?

Are Your Patients Asking about Wegovy?

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories